Introduction Alliqua, Inc. is a biomedical company that specializes in creating and manufacturing innovative technologies for drug delivery, advanced wound care, and liver health preservation. The company aims to produce active ingredient and transdermal drug delivery products, leveraging its proprietary hydrogel technology platform developed by subsidiary AquaMed Technologies, Inc. One of Alliqua's key products is HepaMate, an extracorporeal cell-based bioartificial liver system designed to provide whole liver function for patients with severe liver failure. This system integrates blood detoxification with liver cell therapy. Founded in 1997 and headquartered in New York, NY, the company was previously known as HepaLife Technologies, Inc. before changing its name in 2011. |